Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · BIO KEY INTERNATIONAL INC (BKYI)

BIO-key adjourns annual meeting to October 2 after Proposal 4 lacks sufficient votes

Neutral Impact 3 of 5 shareholder Written later

BIO-key International said its 2026 Annual Meeting of Stockholders, convened September 3, 2026, lacked enough votes to approve Proposal 4, which covers issuing up to 1,236,668 shares on exercise of warrants from its August 10, 2026 warrant inducement transaction. The company adjourned the meeting to October 2, 2026, and asked stockholders who have not voted on Proposal 4 to submit a new proxy, which matters because the share issuance is needed to meet Nasdaq listing rules.

Key points

  • Proposal 4 would approve up to 1,236,668 shares for warrants issued in the August 10, 2026 warrant inducement transaction, for Nasdaq Listing Rule 5635(d) purposes.
  • The Annual Meeting will reconvene on Friday, October 2, 2026, at 10:00 a.m. local time in Holmdel, NJ.
  • The record date remains July 15, 2026; stockholders who have already voted and do not want to change their vote need not act.

The filing

CompanyBIO KEY INTERNATIONAL INC (BKYI)
Form8-K, current report
Filed with the SECSep 8, 2026, 5:04 PM ET
Accession number0001437749-26-029849

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 08, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.